Weng Y Lee

Title: Weng Y Lee: Innovator in Tolerogenic Conjugates

Introduction

Weng Y Lee is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of immunology through his innovative work on tolerogenic conjugates. With a total of 3 patents, his inventions focus on suppressing the formation of reaginic antibodies in sensitive individuals.

Latest Patents

Weng Y Lee's latest patents include:

1. **Penicillin-polyvinyl alcohol conjugate and process of preparation** - This invention relates to tolerogenic conjugates suitable for use in suppressing the formation of reaginic antibodies in a host, particularly targeting the benzylpenicilloyl (BPO) group and 2,4-dinitrophenyl (DNP) group. The conjugates are made with water-soluble, nonimmunogenic polymers, specifically polyvinyl alcohols (PVA). The invention also includes methods for preparing the conjugate and suppressing antibody formation in mammals sensitive to penicillin.

2. **Suppression of reaginic antibodies to drugs employing polyvinyl alcohol** - Similar to his previous patent, this invention also focuses on tolerogenic conjugates that suppress reaginic antibodies in hosts. It utilizes the same haptenic determinants and polymers, providing a method for preparation and application in sensitive mammals.

Career Highlights

Throughout his career, Weng Y Lee has worked with various companies, including Pharmacia AB. His innovative research has positioned him as a key figure in the development of new therapeutic approaches to drug sensitivity.

Collaborations

Weng Y Lee has collaborated with notable individuals in his field, including Alec Sehon. Their joint efforts have contributed to advancements in immunological research and applications.

Conclusion

Weng Y Lee's work in developing tolerogenic conjugates represents a significant advancement in the field of immunology. His patents reflect a commitment to improving the lives of individuals sensitive to certain drugs.